GLOBUS MEDICAL, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
GLOBUS MEDICAL, INC. (GMED) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $13.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $13.42M, a 2.05% increase year-over-year.
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $12.79M, a 4.02% decline year-over-year.
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $11.51M, a 6.46% decline year-over-year.
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $13.15M, a 2.41% increase year-over-year.
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $49.34M, a 9.12% decline from fiscal 2024.
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $54.29M, a 2.87% increase from fiscal 2023.
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $52.77M, a 57.69% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $33.47M, a 7.08% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.42M 10-Q · filed 2026-08-06 | $26.21M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $12.79M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $49.34M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $11.51M 10-Q · filed 2025-11-06 | $24.66M derived: sum of 2 quarters · filed 2026-08-06 | $37.99M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $13.15M 10-Q · filed 2026-08-06 | $26.48M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $13.32M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $54.29M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $12.30M 10-Q · filed 2025-11-06 | $25.15M derived: sum of 2 quarters · filed 2025-11-06 | $42.43M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $12.84M 10-Q · filed 2025-11-06 | $30.13M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $17.28M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $52.77M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $22.76M 10-Q · filed 2024-11-05 | $31.39M derived: sum of 2 quarters · filed 2024-11-05 | $40.43M derived: sum of 3 quarters · filed 2024-11-05 | $49.09M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $8.64M 10-Q · filed 2024-11-05 | $17.67M derived: sum of 2 quarters · filed 2024-11-05 | $26.33M derived: sum of 3 quarters · filed 2024-11-05 | $34.76M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-03-31 | $9.03M 10-Q · filed 2024-11-05 | $17.69M derived: sum of 2 quarters · filed 2024-11-05 | $26.13M derived: sum of 3 quarters · filed 2024-11-05 | $34.15M derived: sum of 4 quarters · filed 2024-11-05 |
| 2022-12-31 | $8.66M 10-K · filed 2023-02-21 | $17.09M derived: sum of 2 quarters · filed 2023-11-07 | $25.11M derived: sum of 3 quarters · filed 2023-11-07 | $33.47M 10-K · filed 2025-02-20 |
| 2022-09-30 | $8.43M 10-Q · filed 2023-11-07 | $16.45M derived: sum of 2 quarters · filed 2023-11-07 | $24.81M derived: sum of 3 quarters · filed 2023-11-07 | $32.77M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $8.02M 10-Q · filed 2023-11-07 | $16.37M derived: sum of 2 quarters · filed 2023-11-07 | $24.34M derived: sum of 3 quarters · filed 2023-11-07 | $31.96M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-03-31 | $8.35M 10-Q · filed 2023-11-07 | $16.32M derived: sum of 2 quarters · filed 2023-11-07 | $23.94M derived: sum of 3 quarters · filed 2023-11-07 | $31.72M derived: sum of 4 quarters · filed 2023-11-07 |
| 2021-12-31 | $7.96M 10-K · filed 2023-02-21 | $15.58M derived: sum of 2 quarters · filed 2023-02-21 | $23.37M derived: sum of 3 quarters · filed 2023-02-21 | $31.25M 10-K · filed 2024-02-21 |
| 2021-09-30 | $7.62M 10-K · filed 2023-02-21 | $15.41M derived: sum of 2 quarters · filed 2023-02-21 | $23.29M derived: sum of 3 quarters · filed 2023-02-21 | $29.29M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $7.79M 10-K · filed 2023-02-21 | $15.67M derived: sum of 2 quarters · filed 2023-02-21 | $21.67M derived: sum of 3 quarters · filed 2023-02-21 | $28.67M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $7.88M 10-K · filed 2023-02-21 | $13.88M derived: sum of 2 quarters · filed 2023-02-21 | $20.89M derived: sum of 3 quarters · filed 2023-02-21 | $28.31M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $6.00M 10-K · filed 2023-02-21 | $13.00M derived: sum of 2 quarters · filed 2023-02-21 | $20.43M derived: sum of 3 quarters · filed 2023-02-21 | $27.33M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-09-30 | $7.01M 10-K · filed 2023-02-21 | $14.43M derived: sum of 2 quarters · filed 2023-02-21 | $21.34M derived: sum of 3 quarters · filed 2023-02-21 | $27.85M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-06-30 | $7.43M 10-K · filed 2023-02-21 | $14.33M derived: sum of 2 quarters · filed 2023-02-21 | $20.84M derived: sum of 3 quarters · filed 2023-02-21 | $27.82M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-03-31 | $6.90M 10-K · filed 2023-02-21 | $13.42M derived: sum of 2 quarters · filed 2023-02-21 | $20.40M derived: sum of 3 quarters · filed 2023-02-21 | $26.78M derived: sum of 4 quarters · filed 2023-02-21 |
| 2019-12-31 | $6.52M 10-K · filed 2022-02-17 | $13.49M derived: sum of 2 quarters · filed 2022-02-17 | $19.88M derived: sum of 3 quarters · filed 2022-02-17 | $26.42M 10-K/A · filed 2020-03-02 |
| 2019-09-30 | $6.98M 10-K · filed 2022-02-17 | $13.36M derived: sum of 2 quarters · filed 2022-02-17 | $19.90M 10-Q · filed 2019-11-06 | $24.83M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-06-30 | $6.38M 10-K · filed 2022-02-17 | $12.92M 10-Q · filed 2019-08-01 | $17.85M derived: sum of 3 quarters · filed 2022-02-17 | $23.48M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-03-31 | $6.54M 10-K · filed 2022-02-17 | $11.47M derived: sum of 2 quarters · filed 2022-02-17 | $17.10M derived: sum of 3 quarters · filed 2022-02-17 | $22.65M derived: sum of 4 quarters · filed 2022-02-17 |
| 2018-12-31 | $4.93M 10-K · filed 2021-02-17 | $10.56M derived: sum of 2 quarters · filed 2021-02-17 | $16.11M derived: sum of 3 quarters · filed 2021-02-17 | $22.22M 10-K/A · filed 2020-03-02 |
| 2018-09-30 | $5.63M 10-K · filed 2021-02-17 | $11.18M derived: sum of 2 quarters · filed 2021-02-17 | $17.29M 10-Q · filed 2019-11-06 | $21.37M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-06-30 | $5.55M 10-K · filed 2021-02-17 | $11.66M 10-Q · filed 2019-08-01 | $15.74M derived: sum of 3 quarters · filed 2021-02-17 | $19.38M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-03-31 | $6.11M 10-K · filed 2021-02-17 | $10.19M derived: sum of 2 quarters · filed 2021-02-17 | $13.83M derived: sum of 3 quarters · filed 2021-02-17 | $17.45M derived: sum of 4 quarters · filed 2021-02-17 |
| 2017-12-31 | $4.08M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $7.72M derived: sum of 2 quarters · filed 2020-03-02 | $11.34M derived: sum of 3 quarters · filed 2020-03-02 | $14.88M 10-K/A · filed 2020-03-02 |
| 2017-09-30 | $3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $7.26M derived: sum of 2 quarters · filed 2017-11-09 | $10.81M 10-Q · filed 2017-11-09 | $13.82M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $7.16M 10-Q · filed 2017-08-03 | $10.17M derived: sum of 3 quarters · filed 2019-02-21 | $12.98M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $3.54M 10-Q · filed 2017-05-04 | $6.55M derived: sum of 2 quarters · filed 2019-02-21 | $9.36M derived: sum of 3 quarters · filed 2019-02-21 | $12.35M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $5.82M derived: sum of 2 quarters · filed 2019-02-21 | $8.81M derived: sum of 3 quarters · filed 2019-02-21 | $11.65M 10-K · filed 2019-02-21 |
| 2016-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $5.80M derived: sum of 2 quarters · filed 2016-11-09 | $8.64M 10-Q · filed 2016-11-09 | $11.43M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $5.83M 10-Q · filed 2016-07-27 | $8.62M derived: sum of 3 quarters · filed 2018-02-22 | $11.02M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $2.84M 10-Q · filed 2016-05-04 | $5.63M derived: sum of 2 quarters · filed 2018-02-22 | $8.03M derived: sum of 3 quarters · filed 2018-02-22 | $10.57M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $5.19M derived: sum of 2 quarters · filed 2018-02-22 | $7.73M derived: sum of 3 quarters · filed 2018-02-22 | $9.86M 10-K · filed 2018-02-22 |
| 2015-09-30 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $4.94M derived: sum of 2 quarters · filed 2015-11-04 | $7.08M 10-Q · filed 2015-11-04 | $8.97M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $4.67M 10-Q · filed 2015-07-31 | $6.57M derived: sum of 3 quarters · filed 2017-03-16 | $8.23M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $2.13M 10-Q · filed 2015-05-05 | $4.03M derived: sum of 2 quarters · filed 2017-03-16 | $5.69M derived: sum of 3 quarters · filed 2017-03-16 | $7.32M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $3.56M derived: sum of 2 quarters · filed 2017-03-16 | $5.18M derived: sum of 3 quarters · filed 2017-03-16 | $7.11M 10-K · filed 2017-03-16 |
| 2014-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $3.28M derived: sum of 2 quarters · filed 2014-10-31 | $5.21M 10-Q · filed 2014-10-31 | $6.52M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $3.55M 10-Q · filed 2014-08-06 | $4.86M derived: sum of 3 quarters · filed 2016-02-29 | $6.25M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.93M 10-Q · filed 2014-04-30 | $3.24M derived: sum of 2 quarters · filed 2016-02-29 | $4.63M derived: sum of 3 quarters · filed 2016-02-29 | $5.79M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.70M derived: sum of 2 quarters · filed 2016-02-29 | $3.87M derived: sum of 3 quarters · filed 2016-02-29 | $5.18M 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $2.55M derived: sum of 2 quarters · filed 2013-10-31 | $3.87M 10-Q · filed 2013-10-31 | $4.82M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $2.48M 10-Q · filed 2013-08-02 | $3.43M derived: sum of 3 quarters · filed 2015-02-26 | |
| 2013-03-31 | $1.31M 10-Q · filed 2013-05-03 | $2.27M derived: sum of 2 quarters · filed 2015-02-26 | ||
| 2012-12-31 | $953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $4.63M 10-K · filed 2015-02-26 | ||
| 2012-09-30 | $3.68M 10-Q · filed 2012-11-02 | |||
| 2011-12-31 | $3.29M 10-K · filed 2014-03-14 | |||
| 2010-12-31 | $4.03M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |